The Impact of Obesity on Disease Severity and Outcomes Among Hospitalized Children With - COVID-19
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
RESEARCH ARTICLE The Impact of Obesity on Disease Severity and Outcomes Among Hospitalized Children With COVID-19 Sandeep Tripathi, MD, MS,a Amy L Christison, MD,b Emily Levy, MD,c Jeremy McGravery, MS,d Aysun Tekin, MD,c Dawn Bolliger, BS, MLT,d Vishakha K. Kumar, MD, MBA,e Vikas Bansal, MD, MPH,c Kathleen Chiotos, MD,f Katja M. Gist, M.D,g Heda R. Dapul, MD,h Utpal S. Bhalala, MD,i Varsha P Gharpure, MD,j Julia A. Heneghan, MD,k Neha Gupta, MD,l Erica C. Bjornstad, MD, PhD, MPH,m Vicki L Montgomery, M.D,n Allan Walkey, MD,o Rahul Kashyap, MBBS, MBA,c Grace M. Arteaga, MDc On Behalf of the Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID-19 Registry Investigator Group ABSTRACT OBJECTIVE: To describe the impact of obesity on disease severity and outcomes of coronavirus disease 2019 (COVID-19) among hospitalized children. METHODS: This retrospective cohort study from the Society of Critical Care Medicine Viral a Children's Hospital of Respiratory Illness Universal Study registry included all children hospitalized with COVID-19 from Illinois, OSF Saint Francis Medical Centre, Peoria, March 2020 to January 2021. Obesity was defined by Centers for Disease Control and Prevention Illinois; bUniversity of BMI or World Health Organization weight for length criteria. Critical illness definition was adapted Illinois College of Medicine, Peoria, Illinois; from National Institutes of Health criteria of critical COVID. Multivariate mixed logistic and linear c Mayo Clinic, Rochester, regression was performed to calculate the adjusted odds ratio of critical illness and the adjusted Minnesota; dOSF Saint Francis Medical Centre, impact of obesity on hospital length of stay. Peoria, Illinois; eSociety of Critical Care Medicine, RESULTS: Data from 795 patients (96.4% United States) from 45 sites were analyzed, including 251 Mount Prospect, Illinois; f (31.5%) with obesity and 544 (68.5%) without. A higher proportion of patients with obesity were Children's Hospital of Philadelphia, Philadelphia, adolescents, of Hispanic ethnicity, and had other comorbidities. Those with obesity were also more Pennsylvania; gAnschutz likely to be diagnosed with multisystem inflammatory syndrome in children (35.7% vs 28.1%, P = Medical Campus, University of Colorado, .04) and had higher ICU admission rates (57% vs 44%, P < .01) with more critical illness (30.3% vs Aurora, Colorado; 18.3%, P < .01). Obesity had more impact on acute COVID-19 severity than on multisystem h Hassenfeld Children's inflammatory syndrome in children presentation. The adjusted odds ratio for critical illness with Hospital at New York University Langone, New obesity was 3.11 (95% confidence interval: 1.8–5.3). Patients with obesity had longer adjusted length of York City, New York; iThe stay (exponential parameter estimate 1.3; 95% confidence interval: 1.1–1.5) compared with patients Children's Hospital of San Antonio, Baylor College of without obesity but did not have increased mortality risk due to COVID-19 (2.4% vs 1.5%, P = .38). Medicine; San Antonio, Texas; jAdvocate CONCLUSION: In a large, multicenter cohort, a high proportion of hospitalized children from Children's Hospital, Park COVID-19 had obesity as comorbidity. Furthermore, obesity had a significant independent Ridge, Illinois; kUniversity of Minnesota Masonic association with critical illness. Children’s Hospital, Minneapolis, Minnesota; l College of Medicine, University of Oklahoma, Oklahoma City, Oklahoma; m University of Alabama at www.hospitalpediatrics.org Birmingham, Birmingham, DOI:https://doi.org/10.1542/hpeds.2021-006087 Alabama; nUniversity of Copyright © 2021 by the American Academy of Pediatrics Louisville and Norton Children’s Hospital Address correspondence to Sandeep Tripathi, MD, MS, Pediatric Intensive Care OSF Saint Francis Medical Centre, Children's Hospital of Louisville, Louisville, Illinois 540, Glen Oak Ave, Peoria IL 61637. E-mail: sandeept@uic.edu Kentucky; and oSchool of HOSPITAL PEDIATRICS (ISSN Numbers: Print, 2154-1663; Online, 2154-1671). Public Health, Boston University, Boston, A complete list of study group members is included in the Acknowledgments. These investigators served as collaborators and site Massachusetts investigators and should be indexed in PubMed as collaborative coauthors on this manuscript. HOSPITAL PEDIATRICS Volume 11, Issue 11, November 2021 e297 Downloaded from www.aappublications.org/news by guest on November 6, 2021
Coronavirus disease 2019 (COVID-19), the METHODS neonate (#28 days), infant (28 days to
replacement therapy (acute dialysis or nonnormal distribution, LOS was log- were significantly older (13 [7.0–16.0] vs continuous renal replacement therapy). transformed, and parameter estimates 5.3 [0.8–13.0] years, P < .01), with more This classification was modified from the and CIs were exponentiated. LOS analysis adolescents composing the group with National Institutes of Health (NIH) was initially performed after the inclusion obesity compared with the group without definition of critical COVID-1926 and was of ICU admission status, diagnosis of MIS- (57.4% [144 of 251] vs 30.5% [166 of previously described by our group.2 C, critical illness, and involvement of 544], P < .01). There was no difference multiple organ systems because of their in the sex or race distribution among the Statistical Analysis potential impact on the LOS. Mediator 2 groups; however, there was a much Standard descriptive statistics were analysis as described by Baron and higher proportion of patients of Hispanic performed for continuous and categorical Kenny29 indicated at least partial ethnicity in patients with obesity (47.8% variables and reported as median with mediation of the impact of obesity on LOS [108 of 251] vs 32.9% [158 of 544], P < interquartile range (IQR) and number with by these variables. These variables were .01). Patients from the United States percentages. The nonparametric Wilcoxon thus excluded from the linear regression made up 96.4% (767 of 795) of the total rank test and v2/Fisher’s exact test were model presented. Complete mediator cohort, with a higher proportion of used as appropriate. Multivariable logistic analysis for the LOS model is provided in patients from the United States in the regression was performed to assess the Supplemental Table 7. Patients with obese category (99.2% [249 of 251] vs risk factors associated with critical illness hospital mortality (n = 14) were excluded 95.2% [518 of 544]). Patients with obesity for the whole cohort and independently from the LOS multivariable analysis. were more likely to have a diagnosis of for patients with obesity. The odds ratio Models’ goodness of fit was assessed by MIS-C as opposed to acute COVID-19 and 95% CI were calculated. A mixed evaluating the residual plots. All statistical (35.7% [85 of 251] vs 28.1% [147 of 544], logistic regression that included a random analysis was conducted by using JMP (v P = .04) and were more likely to have effect for the site was used to determine 16.0; SAS Institute, Inc, Cary, NC) and an $3 organ system involvement at potential risk factors associated with an open-source statistical program R (V presentation (61.4% [154 of 251] vs increased likelihood of critical illness after 4.0.0). A P value
patients $12 years (Fig 2). Separate analysis for factors associated with critical illness among the cohort with obesity (n = 251) revealed that the presence of $ 2 comorbidities was marginally associated with the critical illness (aOR: 1.90; 95% CI: 1.01–3.58, P = .05) (Supplemental Table 13). On multivariable linear regression including the factors described above (with the addition of country), the presence of obesity was associated with a 30% longer hospital LOS (exponentiated parameter estimate: 1.3; 95% CI: 1.1–1.5), P < .01 (Supplemental Table 14). Disease Course and Outcomes of MIS-C and Acute COVID-19 Among Patients With Obesity Among the 528 patients with acute COVID- 19, 28.9% (153 or 528) had obesity. Patients with obesity in this cohort were older (median age 13.2 vs 4 years, P < .001), more likely to be Hispanic, and had more comorbidities. A higher proportion of those with obesity and acute COVID-19 had critical illness (22% vs 11%, P = .001), required ICU admission (50% vs 33%, P < .001) and/or mechanical ventilation (13% FIGURE 1 Patient selection flow diagram. vs 6.7%, P = .01) ,and had longer hospital LOS (3.8 [IQR: 2.0–7.3] days versus 2.8 [1.5–5.9] days, P = .004) (Supplemental critical illness related to COVID-19 (30.3% Risk Factors for Critical Illness and Table 15). In contrast, although a higher [76 of 251] vs 18.3% [100 of 544], P < .01). Hospital LOS proportion of patients with MIS-C had There was a greater need for various obesity (36.6%, 85/232), there was no By using a multivariate mixed logistic organ support interventions, including significant difference in critical illness, ICU regression analysis adjusting for mechanical ventilation, inotropes, and admission, or mechanical ventilation rate covariates including age, race, ethnicity, extracorporeal life support (ECLS), in in patients with MIS-C with obesity and and presence of $2 comorbidities, with a patients with obesity. Among the 5 most compared with those without obesity. random intercept for the site, obesity was prominent complications recorded in the However, a similar increased LOS occurred independently associated with an registry, only acute kidney injury was among the MIS-C cohort with obesity as significantly more common in those with increased odds ratio of critical illness for those with acute COVID-19 (8.0 [IQR: obesity (12.7% [32 of 251 vs 6.8% [37 of (adjusted odds ratio [aOR]: 3.11 [95% CI: 4.7–10.4] days versus 5.7 [3.1–9.4] days, 544], P < .01). Comparative rates of all 1.84–5.27], P < .01). Other factors P = .01) (Supplemental Table 16). complications in the VIRUS registry are significantly associated with critical illness provided in Supplemental Table 12. The included adolescent age, Black race, and Comparison of Disease Severity unadjusted median hospital LOS of $2 comorbidities. A significant interaction was found between age group and obesity, Among Children and Adolescents in patients with obesity was longer than with obesity having less impact on the Different Weight Categories ($ 2 those without obesity (4.8 [IQR: 2.5–8.9] vs 3.5 [IQR: 1.8–6.9], P < .01). There was no likelihood of critical illness as the patient Years) difference in ICU LOS or the duration of gets older. The adjusted critical illness Comparative analysis across 5 different the ventilator and other modes of oxygen rate for patients with obesity was 23% for weight categories (underweight to severe therapy between the 2 groups. (Table 2)
TABLE 1 Demographics of the Study Population Category Subcategory Total Cohort (n = 795) Nonobese (n = 544) Obese (n = 251) P Age 8.0 (1.6–14.0) 5.31 (0.83–13.0) 13.0 (7.0–16.0)
TABLE 2 Hospital Course and Outcomes Category Subcategory Total Cohort (n = 795) Nonobese (n = 544) Obese(n = 251) P Categorical variables Hospital mortality — 14 (1.7) 8 (1.5) 6 (2.4) .38 ICU admission — 382 (48.0) 239 (43.9) 143 (56.9)
TABLE 3 Comparison of Demographics, Comorbidities, and Outcomes in Different BMI Categories (Children $2 y Only) Category Subcategory Underweight (n = 45) Normal (n = 231) Overweight(n = 79) Obese (n = 120) Severely Obese (n = 107) Pa Age 7 (4–12.5) 11 (5.4–15) 11.5 (8–15) 12.9 (7.8–16) 14 (10.9–16)
poor prognosis with adult obesity in the hospitalized with acute COVID-19. Salvagio Campbell, Cathleen Wilson, Patrick youngest age group with progressive Hospitalized children with obesity are Rivers, Jonathan Brinks, Mokenge Ndiva decreases in higher age groups. To the more likely to have critical illness than Mongoh, Boris Gilson (Banner University best of our knowledge, we are the first to hospitalized children without obesity. Medical Center-Tucson); Valerie C. Danesh, report this interaction in the pediatric Although adolescents made up a higher Gueorgui Dubrocq, Amber L. Davis, Marissa population. proportion of patients with obesity, J Hammers, ill M. McGahey, Amanda C. This study has limitations inherent to adolescent age was itself an independent Farris, Elisa Priest, Robyn Korsmo, Lorie those with other retrospective registry risk for critical illness, thereby potentially Fares, Kathy Skiles, Susan M. Shor, Kenya analyses. A complete case analysis such decreasing the impact of obesity on Burns, Corrie A Dowell, Gabriela “Hope” as ours assumes data are missing critical illness within this group. Gonzales, Melody Flores, Lindsay Newman, completely at random. If this assumption Debora A Wilk, Jason Ettlinger, Jaccallene is not met, there is potential for bias. The Acknowledgments Bomar, Himani Darji, Alejandro Arroliga, VIRUS registry employs robust data Society of Critical Care Medicine Discovery Alejandro C Arroliga, Corrie A. Dowell, missingness review and cross-validation Viral Infection and Respiratory Illness Gabriela Hope Conzales, Melody Flores, process with a weekly report to the Universal Study (VIRUS): COVID-19 Registry Lindsay Newman, Debora A. Wilk, Jason investigators. However, there is still a Ettlinger, Himani Darji, Jaccallene Bomar Investigator Group Coauthors: possibility of data entry errors. Because of (Baylor Scott & White Health); Paras B. From Croatia: Tanja Kovacevic, Josko Khandhar, Elizabeth Kring (Beaumont the limitation of the deidentified data set, Markic, Tatjana Catipovic Ardalic, Branka further source verification could not be Children's Hospital); Aaron S. Miller, Edwin Polic, Ivo Ivic, Dominko Carev, Robert L. Anderson, Rosemary Nagy, Ravali R. Inja conducted for this analysis. A high Glavinic (University Hospital of Split); from (Cardinal Glennon Children's Hospital); proportion of hospitalized children have India: Umamaheswara Raju, Janaki Grace Arteaga, Emily Levy, Aysun Tekin, incidental positive polymerase chain Manduva, Naresh Kolakani, Shreeja Sripathi, Rahul Kashyap, Mayank Sharma, Vikas reaction of SARS-CoV-244,45; these patients Sheetal Chaitanya (Gandhi Medical College Bansal, Neha Deo, Shahraz Qamar, Romil were excluded from the registry. However, and Hospital, Hyderabad); Surapaneni Singh, Marija Bogojevic (Children’s Center, the distinction of incidental diagnosis was Krishna Mohan, Ekambaram Jyothisree Mayo Clinic Rochester); Kathleen Chiotos, made by the site investigators. Because of (Panimalar Medical College Hospital & Allison M. Blatz, Giyoung Lee, Ryan H. the evolving understanding of the varied Research Institute); from Pakistan: Sidra Burnett, Guy I. Sydney, Danielle M. Traynor COVID-19 presentations, this may have Ishaque, Ali Faisal Saleem, Naveed Ur (Children's Hospital of Philadelphia); Margit resulted in variability of this Rehman Siddiqui, Salima Sherali, Yasmin Kaufman, Gregg Lobel, Nisha Gandhi, Amr characterization leading to a slight over Hashwani, Shafia Ishaque (The Aga Khan Abdelaty, Elizabeth Shaji, Kiana Lim, Juan and/or under the inclusion of patients. University Hospital); Muhammad Sohaib Marte, Dani Ashley Sosa (Englewood Health); Variables chosen for the logistic and Asghar, Mashaal Syed, Syed Anosh Ali Naqvi Smith F. Heavner-Sullivan, Prera J. Roth, linear regression models were based on (Dow University Hospital); from Saudi Banu Sivaraj, Haley Fulton, Madison G Herin, the current theoretical understanding of Arabia: Mohammed A Almazyad, Mohammed Marissa Crum, Morgan E. Fretwell, Emily- the risk. There might be other variables I Alarifi, Jara M Macarambon, Ahmad Rose Zhou (Greenville Memorial Hospital); associated with critical illness or longer Abdullah Bukhari, Hussain A. Albahrani, Kazi Heda R. Dapul, Sourabh Verma, Alan Salas, LOS that were not included in our model N Asfina, Kaltham M Aldossary (King Saud Ariel Daube, Michelle Korn, Michelle and could confound the association of University); from United States: Varsha P Ramirez, Logi Rajagopalan, Laura Santos obesity. A composite index such as critical Gharpure, Usman Raheemi (Advocate (Hassenfeld Children's Hospital at NYU illness gives equal weightage to every Children's Hospital, IL); Suzanne Barry, Langone); Asher G Bercow, Mark Shlomovich component of the index, each of which may not be similar from a patient Christopher Woll, Gregory Wu, Erin Carrole, (Jacobi Medical Center); J.H. Steuernagle perspective (eg, mortality and noninvasive Kathryn Burke, Mustafa Mohammed (Albany (Johns Hopkins School of Medicine); Melissa ventilation are provided the same rank). Medical Center); Catherine A. St Hill, Roman Thomas, Sarah Morris, Jennifer Nason Although derived from NIH classification, R. Melamed, David M. Tierney, Love A. Patel, (KCPCRU at Norton Children’s Hospital the critical illness definition uses objective Vino S. Raj,Barite U. Dawud, Narayana Louisville); Manoj K Gupta, Franscene E. parameters to identify patients and may Mazumder, Abbey Sidebottom, Alena M. Oulds, Akshay Nandavar (Lincoln Medical miss some patients who would otherwise Guenther, Benjamin D. Krehbiel, Nova J. Center); Andy Y. Wen, Allie DaCar (Lucile qualify for NIH classification of critical Schmitz, Stacy L. Jepsen (Allina Health: Packard Children's Hospital Stanford); Julia illness and vice versa. Abbott Northwestern Hospital, United A. Heneghan, Ronald A. Reilkoff, Sarah Hospital, and Mercy Hospital in Minnesota); Eichen, Lexie Goertzen, Scott Rajala, CONCLUSIONS Katherine Irby, Ronald C. Sanders Jr, Glenda Ghislaine Feussom, Ben Tang (M Health- We report obesity as a risk factor for Hefley (Arkansas Children's Hospital); Fairview, University of Minnesota); Amy B. disease severity in pediatric patients Jarrod M Mosier, Karen Lutrick, Beth Christie, Dennis W. Ashley, Rajani Adiga e304 TRIPATHI et al Downloaded from www.aappublications.org/news by guest on November 6, 2021
(Medical Center Navicent Health); Prithvi (SUNY Upstate Medical University); Neha Omalay, Haleh Hashemighouchani, Julie S. Sendi, Meghana Nadiger, Balagangadhar Gupta, Brent R Brown, Tracy L Jones, Cupka, Matthew M Ruppert (University of Totapally (Nicklaus Children’s Hospital); Kassidy Malone, Lauren A Sinko, Amy B Florida Health Shands Hospital); Patrick Bhagat S. Aulakh, Sandeep Tripathi, Harrell, Shonda C Ayers, Lisa M Settle, W. McGonagill, Colette Galet, Janice Jennifer A. Bandy, Lisa M. Kreps, Dawn R. Taylor J Sears (The Children's Hospital at Hubbard, David Wang, Lauren Allan, Bollinger, Jennifer A. Bandy (OSF Saint OU Medicine); Utpal S. Bhalala, Joshua Aditya Badheka, Madhuradhar Chegondi Francis Medical Center); Shina Menon, Kuehne, Melinda Garcia, Morgan Beebe, (University of Iowa Carver College of John K McGuire, Deana Rich (Seattle Heather Herrera (The Children's Hospital Medicine); Murtaza Akhter, Rania Abdul Children's Hospital); Harry L. Anderson, of San Antonio, Baylor College of Rahman, Mary Mulrow (Valleywise Health, III, Dixy Rajkumar, Ali Abunayla, Jerrilyn Medicine); Katherine A. Belden, Michael formerly Maricopa Medical Center); Heiter (St Joseph Mercy Ann Arbor, Ann Baram, Devin M. Weber, Rosalie DePaola, Markos G. Kashiouris, Tamas Gal, Manasi Arbor); Howard A. Zaren, Stephanie J. Yuwei Xia, Hudson Carter, Aaron Tolley, Mahashabde, Alexandra Vagonis, Rebecca Smith, Grant C. Lewis, Lauren Seames, Mary Barletta (Thomas Jefferson Uber, Haseeb Mahmud, Stefan Leightle, Cheryl Farlow, Judy Miller, Gloria University Hospital); Erica C. Bjornstad, Zoe Zhang, Nicole Vissichelli, Oliver Broadstreet (St Joseph's Candler Health Nancy M. Tofil, Scott House, Isabella Karam, Alia O'Meara, Heloisa De Carvalho, System); John Lin, Cindy Terrill, Brock Aldana (University of Alabama at Katie Rocawich (Virginia Commonwealth Montgomery, Sydney Reyes, Summer Birmingham); Casey W Stulce, Grace University Medical Center); Ashish K Reyes, Alex Plattner (St Louis Children’s Chong, Ahmeneh Ghavam, Anoop Khanna, Lynne Harris, Bruce Cusson, Hospital); Anthony Martinez, Micheal Mayampurath (University of Chicago); Jacob Fowler, David Vaneenenaam, Glen Allison, Aniket Mittal, Rafael Ruiz, Aleta Katja M. Gist, Imran A Sayed, John McKinney, Imoh Udoh, Kathleen Johnson Skaanland, Robert Ross (StAgnes Brinton, Larisa Strom (University of (Wake Forest University School of Hospital); William Marx, Ioana Amzuta, Colorado Anschutz Medical Campus); Azra Medicine; Wake Forest Baptist Health Asad J. Choudhry, Mohammad T. Azam Bihorac, Tezcan Ozrazgat Baslanti, George Network). Access to deidentified patient data are dependent on guidelines of the VIRUS registry. Further information about access to de-identified data from the VIRUS registry can be requested from Dr Vishakha Kumar at vkumar@sccm.org This trial has been registered at www.clinicaltrials.gov (identifier NCT 04323787). Dr Tripathi designed the study, designed the data collection instruments, obtained data from the Viral Respiratory Illness Universal Study (VIRUS) registry, conducted the initial analysis and interpretation, and supervised the literature search and drafted the initial manuscript and the final manuscript; Dr Arteaga conceptualized the study, assisted in the literature search and drafting of the initial manuscript, and reviewed the final manuscript and provided critical input for intellectual content; Dr Christison and Dr Levy assisted in the concept and design of the study, literature search, and drafting of the initial manuscript; Mr McGarvey performed statistical analysis and interpretation for the manuscript; Dr Tekin, Ms Bolliger, Dr Chiotos, Dr Gist, Dr Dapul, Dr Bhalala, Dr Gharpure, Dr Heneghan, Dr Gupta, Dr Bjornstad, and Dr Montgomery supervised or performed data collection at their sites and assisted in the review and provided critical input for intellectual content; Dr Kashyap, Dr Walkley, and Dr Kumar are the principal investigators of the VIRUS registry, conceptualized and designed the data collection instruments (REDCap) for the registry, and reviewed and provided critical input for intellectual content; Dr Bansal assisted in data collection and extraction for this manuscript from the VIRUS registry and reviewed the final manuscript and provided necessary inputs in design and analysis; and all authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work. FINANCIAL DISCLOSURE: E.R.L. receives funding from the Centers for Disease Control and Prevention (CDC) (Subcontract of Federal Contract: 75D30120C07725) and the National Institute of Allergy and Infectious Diseases (National Institute of Allergy and Infectious Diseases Federal Contract: AI144301). They had no influence on the acquisition, analysis, interpretation, and reporting of pooled data for this manuscript. K.C. funded by Agency for Healthcare Research and Quality [K12-HS026393]. No conflict of interest. R.K. receives funding from the National Institutes of Health/National Heart, Lung and Blood Institute: R01HL 130881, UG3/UH3HL 141722; Gordon and Betty Moore Foundation Janssen Research & Development, LLC; and royalties from Ambient Clinical Analytics. Inc. They had no influence on the acquisition, analysis, interpretation, and reporting of pooled data for this manuscript. V.K.K. receives funding from the Gordon and Betty Moore Foundation, CDC Foundation through the University of Washington, and Janssen Research & Development, LLC. They had no influence on the acquisition, analysis, interpretation, and reporting of pooled data for this manuscript. U.S.B is currently funded by National Institutes of Health (Site-principal investigator for Stress Hydrocortisone in Pediatric Septic Shock - R01HD096901), The Children's Hospital of Philadelphia (Site-PI for Pediatric Resuscitation Quality Collaborative - PediResQ), Voelcker Pilot Grant (principal investigator for a project on Pre-Arrest Electrocardiographic Changes), The Children's Hospital of San Antonio Endowed Chair Funds for ancillary projects related to SCCM VIRUS (COVID-19) Registry and SCCM VIRUS EMR automation pilot. No conflict of interest. A.L.C. is funded by the National Institute of Allergy and Infectious Disease: U01AI138907. All other authors have indicated they have no financial relationships relevant to this article to disclose. FUNDING: The registry is funded in part by the Gordon and Betty Moore Foundation and Janssen Research & Development, LLC. Funding sources had no influence on the acquisition, analysis, interpretation, and reporting of pooled data for this manuscript. POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose. In this study, we leverage data from the Society of Critical Care Medicine VIRUS registry on 795 patients from 45 sites to describe the impact of obesity on disease severity with COVID-19 in children. HOSPITAL PEDIATRICS Volume 11, Issue 11, November 2021 e305 Downloaded from www.aappublications.org/news by guest on November 6, 2021
REFERENCES 11. Kim J, Nam JH. Insight into the 20. U.S Food & Drug Administration. relationship between obesity-induced Pediatric exclusivity study age group. 1. Shekerdemian LS, Mahmood NR, Wolfe low-level chronic inflammation and 2014. Available at: https://www.fda.gov/ KK, et al; International COVID-19 PICU COVID-19 infection. Int J Obes. 2020; drugs/ Collaborative. Characteristics and 44:1541–1542 data-standards-manual-monographs/ outcomes of children with coronavirus 12. World Health Organization. WHO obesity pediatric-exclusivity-study-age-group. disease 2019 (COVID-19) infection rates. WHO releases guidelines to Accessed October 25, 2020. admitted to US and Canadian pediatric intensive care units. JAMA Pediatr. address overweight and obesity in 21. Centers for Disease Control and 2020;174(9):868–873 children. 2017. Available at: https://www. Prevention. A SAS program for the 2000 who.int/nutrition/topics/new-release- CDC growth charts (ages 0 to
org/course/course-v1:HarvardX+PH559x 35. Gao M, Piernas C, Astbury NM, et al. Characteristics and outcomes of US +2T2020/home. Accessed xxxx Associations between body-mass index children and adolescents with 29. Baron RM, Kenny DA. The moderator- and COVID-19 severity in 6·9 million multisystem inflammatory syndrome in mediator variable distinction in social people in England: a prospective, children (MIS-C) compared with severe psychological research: conceptual, community-based, cohort study. Lancet acute COVID-19. JAMA. strategic, and statistical considerations. Diabetes Endocrinol. 2021;9(6):350–359 2021;325(11):1074–1087 J Pers Soc Psychol. 1986;51(6):1173–1182 36. Zhu Z, Hasegawa K, Ma B, Fujiogi M, 42. Consiglio CR, Cotugno N, Sardh F, et al. 30. Vandenbroucke JP, von Elm E, Altman Camargo CA Jr, Liang L. Association of The immunology of multisystem DG, et al; STROBE Initiative. Strengthening obesity and its genetic predisposition inflammatory syndrome in children with the Reporting of Observational Studies in with the risk of severe COVID-19: Analysis COVID-19. Cell. 2020;183(4):968–981 e967 Epidemiology (STROBE): explanation and of population-based cohort data. 43. Hendren NS, de Lemos JA, Ayers C, et al. elaboration. PLoS Med. 2007;4(10):e297 Metabolism. 2020;112:154345 Association of body mass index and age 31. Sanchis-Gomar F, Lavie CJ, Mehra MR, 37. Elagizi A, Kachur S, Lavie CJ, et al. An with morbidity and mortality in patients Henry BM, Lippi G. Obesity and outcomes overview and update on obesity and the hospitalized with COVID-19: results from in COVID-19: when an epidemic and obesity paradox in cardiovascular the American Heart Association COVID-19 pandemic collide. Paper presented at: diseases. Prog Cardiovasc Dis. Cardiovascular Disease Registry. Mayo Clinic Proceedings; 2020 2018;61(2):142–150 Circulation. 2021;143(2):135–144 32. ClinCalc. Post-hoc power calculator, 38. Lakkis JI, Weir MR. Obesity and kidney 44. Webb NE, Osburn TS. Characteristics of evaluate statistical power of an existing disease. Prog Cardiovasc Dis. hospitalized children positive for SARS- study. 2021. Available at: https://clincalc. 2018;61(2):157–167 CoV-2: experience of a large center com/stats/Power.aspx. Accessed June 7, 39. Rutkowski JM, Stern JH, Scherer PE. The [Published online ahead of print May 19, 2021 cell biology of fat expansion. J Cell Biol. 2021]. Hosp Pediatr. doi:https://doi.org/ 33. Kyler KE, Bettenhausen JL, Hall M, Hampl 2015;208(5):501–512 10.1542/hpeds.2021-005919 S. Prevalence and trends in obesity 40. Lee YS, Kim JW, Osborne O, et al. 45. Kushner LE, Schroeder AR, Kim J, among hospitalized children. Hosp Increased adipocyte O2 consumption Mathew R. “For COVID or ”with COVID: Pediatr. 2019;9(11):897–902 triggers HIF-1a, causing inflammation classification of SARS-CoV-2 34. Ross PA, Newth CJ, Leung D, Wetzel RC, and insulin resistance in obesity. Cell. hospitalizations in children [published Khemani RG. Obesity and mortality risk 2014;157(6):1339–1352 online ahead of print May 19, 201]. Hosp in critically ill children. Pediatrics. 41. Feldstein LR, Tenforde MW, Friedman KG, Pediatr. doi:https://doi.org/10.1542/ 2016;137(3):e20152035 et al; Overcoming COVID-19 Investigators. hpeds.2021-006001 HOSPITAL PEDIATRICS Volume 11, Issue 11, November 2021 e307 Downloaded from www.aappublications.org/news by guest on November 6, 2021
The Impact of Obesity on Disease Severity and Outcomes Among Hospitalized Children With COVID-19 Sandeep Tripathi, Amy L Christison, Emily Levy, Jeremy McGravery, Aysun Tekin, Dawn Bolliger, Vishakha K. Kumar, Vikas Bansal, Kathleen Chiotos, Katja M. Gist, Heda R. Dapul, Utpal S. Bhalala, Varsha P Gharpure, Julia A. Heneghan, Neha Gupta, Erica C. Bjornstad, Vicki L Montgomery, Allan Walkey, Rahul Kashyap and Grace M. Arteaga Hospital Pediatrics originally published online June 24, 2021; originally published online June 24, 2021; Updated Information & including high resolution figures, can be found at: Services http://hosppeds.aappublications.org/content/early/2021/10/05/hpeds. 2021-006087 Supplementary Material Supplementary material can be found at: http://hosppeds.aappublications.org/content/suppl/2021/10/05/hpeds. 2021-006087.DCSupplemental References This article cites 31 articles, 7 of which you can access for free at: http://hosppeds.aappublications.org/content/early/2021/10/05/hpeds. 2021-006087#BIBL Subspecialty Collections This article, along with others on similar topics, appears in the following collection(s): Critical Care http://www.hosppeds.aappublications.org/cgi/collection/critical_care _sub Infectious Disease http://www.hosppeds.aappublications.org/cgi/collection/infectious_di seases_sub Obesity http://www.hosppeds.aappublications.org/cgi/collection/obesity_new _sub Permissions & Licensing Information about reproducing this article in parts (figures, tables) or in its entirety can be found online at: http://www.hosppeds.aappublications.org/site/misc/Permissions.xhtm l Reprints Information about ordering reprints can be found online: http://www.hosppeds.aappublications.org/site/misc/reprints.xhtml Downloaded from www.aappublications.org/news by guest on November 6, 2021
The Impact of Obesity on Disease Severity and Outcomes Among Hospitalized Children With COVID-19 Sandeep Tripathi, Amy L Christison, Emily Levy, Jeremy McGravery, Aysun Tekin, Dawn Bolliger, Vishakha K. Kumar, Vikas Bansal, Kathleen Chiotos, Katja M. Gist, Heda R. Dapul, Utpal S. Bhalala, Varsha P Gharpure, Julia A. Heneghan, Neha Gupta, Erica C. Bjornstad, Vicki L Montgomery, Allan Walkey, Rahul Kashyap and Grace M. Arteaga Hospital Pediatrics originally published online June 24, 2021; originally published online June 24, 2021; The online version of this article, along with updated information and services, is located on the World Wide Web at: http://hosppeds.aappublications.org/content/early/2021/10/05/hpeds.2021-006087 Data Supplement at: http://hosppeds.aappublications.org/content/suppl/2021/10/05/hpeds.2021-006087.DCSupplemental Hospital Pediatrics is an official journal of the American Academy of Pediatrics. Hospital Pediatrics is owned, published, and trademarked by the American Academy of Pediatrics, 345 Park Avenue, Itasca, Illinois, 60143. Copyright © 2021 by the American Academy of Pediatrics. All rights reserved. Print ISSN: 1073-0397. Downloaded from www.aappublications.org/news by guest on November 6, 2021
You can also read